When Malaysia Airlines Flight 370 disappeared on its way from Kuala Lumpurto Beijingin 2014, aerospace engineer Payam Banazadeh, then 23, fixated on one question: Why couldn't satellites scan the area where the plane disappeared in real-time?
"As I pulled the thread, what was very clear was that there was a huge gap in monitoring our planet from space," Banazadehsays.
Of thehundreds of schoolbus-size Earth-observation satellites currently in orbit, the majority use optical imaging, which typically can't see 75 percent of the Earth's surface because of weather issues and darkness, according to Banazadeh. At the same time, the cost of sending satellites into orbit is falling dramatically as governments and private companies launch a growing number of rockets into space, creating new opportunities for entrepreneurs to puteyes in the sky.
Banazadeh, a former project manager at NASA, saw a problem he could solve and the perfect moment to do it, so he founded Capella Space in 2016 with the goal of developing a smaller, more powerful satellite. In 2019, the company launched its first prototype satellite Denali, a backpack-size device that uses a technology called Synthetic Aperture Radar (SAR), which can see through clouds and at night.
In 2020, Capella will launch sevensatellites that togetherwill be able to monitor the entire surfaceofthe planeteverysix hours, on average, according to Banazadeh. The company will launch an additional sixto 12 satellites per year until it has 36 in orbit, at which point he says the time between updates will drop from up six hours to up to one hour. Capella will allow customers to submit requests for data and imagery through an automated system in a matter of minutes,16 times faster than rivalcompanies can, according to Banazadeh.
A wide range of applications
Unlike optical imaging satellites, which relyon incominglight to produce an image, Capella's satellites send a radar signalthat hits the Earth's surface and is reflected back to the satellite.The resulting data is used to produce an image that can detect changes tothe Earth's surfaceless than a meter in size. The structural integrity of a bridge, for example, can be monitored over time to determine whether maintenance workneeds to be done.
Although Capella's fleet of satellites isn't commercially operational yet,the companyhas already signed multimillion-dollar contracts with U.S. government agencies, including the U.S. Air Force and the Department of Defense's National Reconnaissance Office. "We will be monitoring certain spots for them and alerting them of any change," Banazadeh says.
The applications for Capella's servicesextendfar beyond providing information for governmentagencies.Banazadehsaysthe companyhas deals in place with private sector customers, thoughhe can't disclose their names.Being able to trackthe supply chain ofmajorcommodities like oil is onecapability hesays will create significant value.And because Capella's radar can also measurethe moisture levels of soil, monitoringthe health of crops for the agricultural industry represents another opportunity. Perhaps the most valuable service will beprovidinginformation tofirst responders during emergencies like storms, fires, andother natural disasters.
"The ability for us to immediately look through the clouds while the storm or disaster is happening, do damage assessment, and provide thatto the first responders to tell them what the best route is--those are the types of interactions we can start having," Banazadeh says.
Lower costs mean greater opportunity
With around 100 rocket launches taking place every year,the cost of sending satellitesinto space has fallen to between $20,000 and $40,000per kilogram. "It used to be that governments would launch these gigantic, billion-dollar satellites into space once every couple years," says Todd Dagres, a co-founder at Spark Capital, one of Capella's investors. "What's happened is, the bar has dropped so precipitously that countries that before could hardly get a train to run on time are pumping iron to the sky."
Elon Musk's SpaceXrecently began offering monthly missions to small satellite operators starting at $1 million, or$5,000 per kilogramfor up to 200 kilograms of payload mass.(In March, Capella's first operational satellite, called Sequoia, is scheduled tolaunch on a SpaceX Falcon 9 rocket from Cape Canaveral, Florida.) Theindustry also has benefited from lower costs for the components required to build small satellites. "A lot of that is driven by the commercial electronics industry--the stuff that is feeding the newest features on our iPhones and laptops,"says Mike Safyan, vice president of launch at Planet, an Earth-observation company that provides satellite imagery data. "That's being folded into the space industry in a way that hasn't really been done before."Capella declined to disclose how much it costs to buildits satellites.
Venture capital investment into space technology companies hasgrown to $2.27 billion in 2019 from $2.6 million in 2011, according to market data provider PitchBook.Capella has raised more than $80 million in funding, primarily from venture capital firms Data Collective andSpark Capital. The global nanosatellite and microsatellite marketis expected to grow to $3.6 billion by 2024 from $1.5 billion in 2019, according to research firm MarketsandMarkets.
Companies that provide satellite observation services similar to Capella's, albeit using much larger satellites, include multinational aerospace corporation Airbus and Italian company e-GEOS.Banazadeh says the value Capella brings is significantlydifferent from what these companies can offer thanks to its constellation that can repeatedly observe specific areas of the planet.
"They have these giant satellites that can do more things thanour satellites can do, but they can't really have the cadence at the cost that we can provide," he says. "I think we're very much complementary with those guys."One startup competitor isJapaneseSAR company Synspective, which raised $100 million in funding last July. Twoof the biggest challenges facing all satellite companies, according to Banazadeh,aresecuring reliable launch vehicles andputting satellites into orbit on time, asrockets are in high demand and launch delays are the norm rather than the exception.
In as soon as the next five years, Banazadehsays Capella's data could be useful for predicting future events, like where illegal fishingis likely to take place.
"If I were looking at that area from space using my satellite and combining it with other satellites and other data--this is the route they take and this is what the boat looks like--the next time I can start predicting who is doing what," he says. "As we start building this really dense data set of high quality and high cadence, that's going to be really interesting."
Published on: Feb 4, 2020
See the original post here:
An Ex-NASA Employee Is Launching Satellites Into Space to Predict the Future and Help Save Lives - Inc.
- The Ethical, Legal, and Social Issues Impacted by Modern ... - Hindawi - November 25th, 2022
- BSGM - The British Society for Genetic Medicine - November 25th, 2022
- Feasibility and ethics of using data from the Scottish newborn blood spot archive for research | Communications Medicine - Nature.com - October 7th, 2022
- Closing your health care practice: What you need to know - Medical Economics - October 7th, 2022
- Is the doctor's office heading for extinction? - Medical Economics - October 7th, 2022
- Abortion Access in the U.S.: What to Know on a State-By-State Level - Healthline - October 7th, 2022
- Students can create their own path with new ASU Online biology degree - ASU News Now - October 7th, 2022
- U.S. Releases an AI Bill Of Rights That Though Encouraging Won't Yet Move the Needle - JURIST - October 7th, 2022
- California Funds Research On Blocking Marijuana Monopolies And Protecting 'Legacy' Cannabis Strains - Marijuana Moment - October 7th, 2022
- Tips For Your Virtual Meetings With The FDA - Med Device Online - October 7th, 2022
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed ... - The Bakersfield Californian - October 7th, 2022
- MeiraGTx Announces the Upcoming Presentation of 15 Abstracts at the European Society of Gene and Cell Therapy (ESGCT) 2022 Annual Congress -... - October 7th, 2022
- Neighborhood deprivation and coronary heart disease in patients with bipolar disorder | Scientific Reports - Nature.com - October 7th, 2022
- Have Insurers Paid Too Much for Asbestos and Other Toxic Torts? - Claims Journal - August 19th, 2022
- Restrictive abortion laws are limiting the options parents have after receiving genetic test results, experts say - Yahoo Singapore News - August 19th, 2022
- Neurologists Discuss the Impact of Roe v. Wade Reversal on... : Neurology Today - LWW Journals - August 19th, 2022
- Abortion ruling prompts variety of reactions from states - ABC News - August 19th, 2022
- Is pregnancy possible after multiple failed IVF attempts? Can your frozen eggs and sperm be as healthy later? - The Indian Express - August 19th, 2022
- Meet the Expert: Focus on orthopaedics and VTE - Hospital Healthcare Europe - August 19th, 2022
- Egg Donation Process: From Application to Recovery - Healthline - July 6th, 2021
- Patent protection of mRNA vaccines and regulatory authorization - Lexology - July 6th, 2021
- EAPM: Presidency bridging conference a great success, HTA compromise agreed and data on the agenda - EU Reporter - July 6th, 2021
- Cell and Gene Therapy Drug Delivery Devices Market, 2030 - Market Opportunities in the Strong Pipeline of Cell and Gene Therapies - PRNewswire - April 4th, 2021
- Legally blind Great Falls filmmakers share their vision in national challenge - Yahoo News - April 4th, 2021
- Pfizer Announces Vaccine Is 100% Protective Against Coronavirus In Kids As Young As 12 - Yahoo News - April 4th, 2021
- How the law will change in 2021 - Lexology - February 11th, 2021
- Writing is the best medicine - The London Economic - February 11th, 2021
- Misleading glyphosate-cancer study Part 2: 'Symptom of a widespread problem'Concerns about ideological activism in science research and communications... - February 11th, 2021
- The Error of Fighting a Public Health War With Medical Weapons - WIRED - January 2nd, 2021
- Moderna, Pfizer vaccine trials were the highest of quality: vaccine expert - Yahoo Money - January 2nd, 2021
- Celebrate the new year with this New Year's Eve fireworks show in SF - Yahoo News - January 2nd, 2021
- The movie industry will strengthen again around April or May: Screenvision CEO - Yahoo Money - January 2nd, 2021
- Congress overrides Donald Trump's veto of a defense policy bill in the first such rebuke of his presidency - Yahoo News - January 2nd, 2021
- How the pandemic enabled a robot revolution - Politico - December 4th, 2020
- The mink link: How COVID-19 mutations in animals affect human health and vaccine effectiveness - The Conversation CA - November 24th, 2020
- How vaccines get made and approved in the US - The Albany Herald - November 24th, 2020
- Legalization votes bring worries of increased youth marijuana use, but evidence remains murky - AberdeenNews.com - November 24th, 2020
- Your daily 6: Third vaccine looks effective, no single 'word of the year' and Trump team called 'a national embarrassment' - Ravalli Republic - November 24th, 2020
- Cybersecurity depends on the user - Modern Diplomacy - November 20th, 2020
- It's Been Exactly One Year Since the First Case of COVID Was Found in China - Newsweek - November 20th, 2020
- Risks and benefits of an AI revolution in medicine - Harvard Gazette - November 12th, 2020
- HHS eased oversight of Covid-19 tests though it knew of problems - STAT - November 3rd, 2020
- Who won this years Nobel science prizes? - The Economist - October 8th, 2020
- Patent and Patient Rights in COVID-19: Is the Right to Exclusivity a Hamlet Question? - The Leaflet - October 8th, 2020
- FDA Oversight of Laboratory-Developed Tests Continues To Evolve - JD Supra - October 8th, 2020
- One Sperm Donor. 36 Children. A Mess of Lawsuits. - The Atlantic - September 15th, 2020
- Nebraska Medical Bill initiative blocked from entering the November ballots - Cannabis Health Insider - September 15th, 2020
- Poaching pressure mounts on jaguars, the Americas' iconic big cat - Mongabay.com - September 15th, 2020
- 'There is a sense of being robbed': Olympian Caster Semenya loses appeal on testosterone rule - The World - September 15th, 2020
- Global Microbiome Sequencing Market Growth Drivers, Demands, Business Opportunities and Demand Forecast to 2026|Clinical-Microbiomics A/S; Diversigen;... - September 5th, 2020
- Legal and Regulatory Issues in Genetic Information ... - August 31st, 2020
- The legal aspects of genetic testing - Medical Defence Union - August 31st, 2020
- Their view: Now is not the time to legalize marijuana - Wilkes Barre Times-Leader - August 31st, 2020
- Weighing up the potential benefits and harms of comprehensive full body health checks - Croakey - August 24th, 2020
- Soon, India will have its dedicated vaccine portal: ICMR - ETHealthworld.com - August 24th, 2020
- Two Families, Two Fates: When the Misdiagnosis is Child Abuse - The Marshall Project - August 22nd, 2020
- Ron Evans steals a trick from I/O, and points the way to a transformational diabetes therapy - Endpoints News - August 22nd, 2020
- Contact tracing apps may be ineffective for reducing Covid-19 spread: Study - ETHealthworld.com - August 22nd, 2020
- Global Microbiome Sequencing Market Size 2020 Review, Growth Strategy, Developing Technologies And Forecast By 2026|Charles River; CoreBiome, Inc.;... - August 19th, 2020
- Bill Jones: Working to create a culture of education - Wilkes Barre Times-Leader - August 19th, 2020
- Whats next for abortion legislation in the U.S.? - PBS NewsHour - July 10th, 2020
- No ethics when it comes to US enemies, even in the middle of a deadly pandemic - IOL - July 10th, 2020
- IML conducts the 5th National Convention on Medicine and Law - ETHealthworld.com - July 10th, 2020
- Wayne Medicine and Wayne Law professors team up to explore legal and ethical issues of wastewater monitoring for COVID-19 - The South End - June 28th, 2020
- Challenge trials aren't the answer to a speedy Covid-19 vaccine - STAT - June 28th, 2020
- Trump Suspends H-1B and Other Visas That Allow Foreigners to Work in the U.S. - The New York Times - June 24th, 2020
- Could the Montreal Neuro herald a paradigm shift in scientific research? - University Affairs - June 24th, 2020
- Next-Generation Sequencing Market: Understanding The Key Product Segments And Their Future During 2020 -2025 - 3rd Watch News - June 24th, 2020
- Meet 'Gastruloid': The First Human Embryo-like Model From Stem Cells That Could Soon Save Many Babie - Science Times - June 12th, 2020
- Could these senolytic drugs halt the spread of COVID-19? - Health Europa - June 12th, 2020
- The coronavirus vaccine frontrunners have emerged. Here's where they stand - BioPharma Dive - June 12th, 2020
- Regulating marine genetic resources in areas beyond national jurisdiction - The Daily Star - June 12th, 2020
- Vaccines have saved millions of lives, but history shows missteps can prove deadly - The Boston Globe - June 12th, 2020
- Quitting smoking might reduce severe coronavirus infection risk: Study - ETHealthworld.com - May 23rd, 2020
- Where Taiwan Can Make the Most of AI - Taiwan - Taiwan Business TOPICS - May 23rd, 2020
- WHO and IOC team up to improve health through sport - ETHealthworld.com - May 18th, 2020
- The Cell Therapy Industry to 2028: Global Market & Technology Analysis, Company Profiles of 309 Players (170 Involved in Stem Cells) -... - May 15th, 2020
- Medical School: Who gets in and why - Stuff.co.nz - May 15th, 2020
- Wilson Ighodalo: Addressing Substance Abuse as a Public Health Problem - THISDAY Newspapers - May 15th, 2020
- The Falsehoods of the 'Plandemic' Video - FactCheck.org - May 14th, 2020